These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Comparison of expected imaging findings following percutaneous microwave and cryoablation of pulmonary tumors: ablation zones and thoracic lymph nodes. Wrobel MM; Cahalane AM; Pachamanova D; Leppelmann KS; Silverman SG; Sharma A; Shyn PB; Mercaldo ND; Fintelmann FJ Eur Radiol; 2022 Dec; 32(12):8171-8181. PubMed ID: 35704108 [TBL] [Abstract][Full Text] [Related]
5. Real-time magnetic resonance imaging-guided cryoablation of small renal tumors at 1.5 T. Ahrar K; Ahrar JU; Javadi S; Pan L; Milton DR; Wood CG; Matin SF; Stafford RJ Invest Radiol; 2013 Jun; 48(6):437-44. PubMed ID: 23511191 [TBL] [Abstract][Full Text] [Related]
6. Characteristic CT Findings After Percutaneous Cryoablation Treatment of Malignant Lung Nodules. Chaudhry A; Grechushkin V; Hoshmand M; Kim CW; Pena A; Huston B; Chaya Y; Bilfinger T; Moore W Medicine (Baltimore); 2015 Oct; 94(42):e1672. PubMed ID: 26496275 [TBL] [Abstract][Full Text] [Related]
7. Computed tomographic appearance of lung tumors treated with percutaneous cryoablation. Ito N; Nakatsuka S; Inoue M; Yashiro H; Oguro S; Izumi Y; Kawamura M; Nomori H; Kuribayashi S J Vasc Interv Radiol; 2012 Aug; 23(8):1043-52. PubMed ID: 22840803 [TBL] [Abstract][Full Text] [Related]
8. Pulmonary Cryoablation Outcomes in Octogenarians and Nonagenarians with Primary Lung Cancer. Mabud TS; Swilling D; Guichet P; Zhu Y; Manduca S; Patel B; Azour L; Taslakian B; Garay SM; Moore W J Vasc Interv Radiol; 2023 Nov; 34(11):2006-2011. PubMed ID: 37527771 [TBL] [Abstract][Full Text] [Related]
9. Percutaneous cryoablation of hepatic tumors: long-term experience of a large U.S. series. Littrup PJ; Aoun HD; Adam B; Krycia M; Prus M; Shields A Abdom Radiol (NY); 2016 Apr; 41(4):767-80. PubMed ID: 26960728 [TBL] [Abstract][Full Text] [Related]
10. Temperature isotherms during pulmonary cryoablation and their correlation with the zone of ablation. Hinshaw JL; Lee FT; Laeseke PF; Sampson LA; Brace C J Vasc Interv Radiol; 2010 Sep; 21(9):1424-8. PubMed ID: 20688532 [TBL] [Abstract][Full Text] [Related]
11. Percutaneous Renal Cryoablation: Short-Axis Ice-Ball Margin as a Predictor of Outcome. Ge BH; Guzzo TJ; Nadolski GJ; Soulen MC; Clark TW; Malkowicz SB; Wein AJ; Hunt SJ; Stavropoulos SW J Vasc Interv Radiol; 2016 Mar; 27(3):403-9. PubMed ID: 26755344 [TBL] [Abstract][Full Text] [Related]
12. Prediction of the critical thermal zone during pulmonary cryoablation on computed tomography from correlated experimental and clinical findings. Hashimoto K; Izumi Y; Yamauchi Y; Yashiro H; Inoue M; Nakatsuka S; Nomori H J Thorac Cardiovasc Surg; 2013 Mar; 145(3):832-8. PubMed ID: 22503202 [TBL] [Abstract][Full Text] [Related]
13. Five-year survival after cryoablation of stage I non-small cell lung cancer in medically inoperable patients. Moore W; Talati R; Bhattacharji P; Bilfinger T J Vasc Interv Radiol; 2015 Mar; 26(3):312-9. PubMed ID: 25735518 [TBL] [Abstract][Full Text] [Related]
14. Assessing ablation margins of FDG-avid liver tumors during PET/CT-guided thermal ablation procedures: a retrospective study. Casadaban LC; Catalano PJ; Lee LK; Hyun H; Tuncali K; Gerbaudo VH; Shyn PB Eur J Nucl Med Mol Imaging; 2021 Aug; 48(9):2914-2924. PubMed ID: 33559712 [TBL] [Abstract][Full Text] [Related]
16. Percutaneous Cryoablation for the Treatment of Recurrent Malignant Pleural Mesothelioma: Safety, Early-Term Efficacy, and Predictors of Local Recurrence. Abtin F; Quirk MT; Suh RD; Hsu W; Han SX; Kim GJ; Genshaft S; Sandberg JK; Olevsky O; Cameron RB J Vasc Interv Radiol; 2017 Feb; 28(2):213-221. PubMed ID: 27979596 [TBL] [Abstract][Full Text] [Related]
17. 18F-FDG PET-CT: predicting recurrence in patients following percutaneous cryoablation treatment for stage I primary non-small-cell lung cancer. LoGiurato B; Matthews R; Safaie E; Moore W; Bilfinger T; Relan N; Franceschi D Nucl Med Commun; 2015 Sep; 36(9):908-13. PubMed ID: 25973693 [TBL] [Abstract][Full Text] [Related]
18. Active Versus Passive Thaw After Percutaneous Cryoablation of Pulmonary Tumors: Effect on Incidence, Grade, and Onset of Hemoptysis. Wrobel MM; Bourgouin PP; Abrishami Kashani M; Leppelmann KS; Vazquez R; Pachamanova DA; Fintelmann FJ AJR Am J Roentgenol; 2021 Nov; 217(5):1153-1163. PubMed ID: 34008999 [No Abstract] [Full Text] [Related]
19. Ablation zone considerations in cryoablation of RCC: accuracy of manufacturer provided model and change from first to second freeze cycle. Young S; Sharma S; Rubin N; Hall D; Anderson JK Clin Imaging; 2022 Sep; 89():10-15. PubMed ID: 35660642 [TBL] [Abstract][Full Text] [Related]
20. Percutaneous cryoablation for the treatment of medically inoperable stage I non-small cell lung cancer. Yamauchi Y; Izumi Y; Hashimoto K; Yashiro H; Inoue M; Nakatsuka S; Goto T; Anraku M; Ohtsuka T; Kohno M; Kawamura M; Nomori H PLoS One; 2012; 7(3):e33223. PubMed ID: 22413004 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]